EcoR1 Capital as of Dec. 31, 2016
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 30 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 14.6 | $44M | 2.9M | 15.29 | |
| Galapagos Nv- (GLPG) | 12.0 | $36M | 561k | 64.19 | |
| Assembly Biosciences | 11.9 | $36M | 2.9M | 12.15 | |
| Alexion Pharmaceuticals | 6.6 | $20M | 162k | 122.35 | |
| Ascendis Pharma A S (ASND) | 6.6 | $20M | 976k | 20.24 | |
| Theravance Biopharma Inc note 3.250%11/0 | 6.5 | $19M | 17M | 1.14 | |
| Ardelyx (ARDX) | 6.2 | $18M | 1.3M | 14.20 | |
| Kura Oncology (KURA) | 5.2 | $15M | 2.6M | 5.90 | |
| Five Prime Therapeutics | 5.0 | $15M | 299k | 50.11 | |
| Aclaris Therapeutics (ACRS) | 3.8 | $11M | 414k | 27.14 | |
| Allergan Plc call | 3.5 | $11M | 50k | 210.02 | |
| Editas Medicine (EDIT) | 3.4 | $10M | 627k | 16.23 | |
| Xencor (XNCR) | 3.3 | $9.9M | 375k | 26.32 | |
| Chimerix (CMRX) | 2.2 | $6.5M | 1.4M | 4.60 | |
| Fastenal Co Cmn Stk cmn | 2.1 | $6.4M | 2.5M | 2.51 | |
| Atara Biotherapeutics | 1.0 | $3.1M | 216k | 14.20 | |
| Adverum Biotechnologies | 0.8 | $2.5M | 874k | 2.90 | |
| Kindred Biosciences | 0.8 | $2.4M | 571k | 4.25 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.7 | $2.1M | 977k | 2.15 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $2.0M | 274k | 7.17 | |
| Egalet | 0.6 | $1.7M | 222k | 7.65 | |
| Nabriva Therapeutics | 0.5 | $1.6M | 265k | 5.96 | |
| Dermira | 0.4 | $1.3M | 43k | 30.32 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $972k | 23k | 41.72 | |
| Chemocentryx | 0.3 | $873k | 118k | 7.40 | |
| Syros Pharmaceuticals | 0.3 | $773k | 64k | 12.15 | |
| Cytokinetics (CYTK) | 0.2 | $667k | 55k | 12.15 | |
| Bristol Myers Squibb (BMY) | 0.2 | $500k | 8.6k | 58.41 | |
| Biopharmx | 0.2 | $497k | 1.3M | 0.37 | |
| Cascadian Therapeutics Inc call | 0.1 | $447k | 104k | 4.31 |
